Recombinant antigen p138 for Epstein-barr virus (EBV)

Epstein-barr virus (EBV)

D-EA p138 is consideres as diffused (EA-D) early antigen. Regarding the EA-D, it is located in nucleus and cytoplasm and it has been described the highly presence of the diffuse early antigen of EBV in lymphomas and lymphoproliferative disorders. The D-EA p138 is an antigen codified by the gene BALF2 which is the major DNA binding protein of EBV. At the time of infection with Epstein-Barr virus, antibodies to EA are found and usually last for four to six months only. The absence of antibody to EA when other EBV antibodies are present strongly suggests that first time infection with EBV occurred in the past.

More information about Epstein-Barr virus infection (EBV).

or
Name
p138
Description
Early antigen
Gene
BALF2
Purity
> 95% by observation on SDS-PAGE electrophoresis
References
SKU Source Applications In-house validation Details
RAG0033 E. coli WB, DB, IE, DE ELISA Example of a certificate of analysis Material Safety Data Sheet
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Formats
Liquid protein solution or dry powder (lyophilised) in vials of 0.1 mg, 1 mg and bulk
Related products

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.

Bact to list of Proteins for human infectious diseases